Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2462,98,6.80 [4.50-10.27],8.998773963826963e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,2461,99,2.82 [2.10-3.78],6.166898630289434e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,2462,98,3.27 [2.29-4.67],8.559137005211861e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,2497,102,3.05 [2.02-4.59],9.876826147534337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,2500,102,10.15 [5.25-19.60],5.342846356455976e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,2496,99,3.64 [2.63-5.04],5.316940193606927e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,2499,102,18.47 [8.97-38.03],2.5029266337719964e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,2500,102,3.47 [2.41-5.01],2.9184323933407913e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,2492,99,3.92 [2.73-5.63],1.484779255358949e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,2486,99,6.08 [3.58-10.34],2.4939271571952308e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,2143,83,4.06 [2.57-6.43],2.215827811055547e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,2475,101,2.60 [1.93-3.49],2.5381333508306816e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,2463,98,4.28 [2.70-6.80],6.764879221341634e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,2148,83,6.23 [3.40-11.40],3.033091081070457e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2130,82,3.91 [2.45-6.26],1.247526457865548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,2143,83,4.04 [2.46-6.66],3.8982069842513176e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2496,99,5.87 [3.27-10.54],2.958568257043593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,2501,101,6.63 [3.46-12.71],1.2535080394036473e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,2496,99,4.83 [3.18-7.34],1.3930974926290134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,2475,101,5.16 [3.46-7.71],8.935621271862618e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,2510,102,2.67 [1.94-3.68],2.1758348887408198e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,2503,102,3.52 [2.48-5.01],2.700984892206589e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,2500,102,3.22 [2.23-4.67],5.821293089332316e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,2490,100,3.67 [2.53-5.34],9.837934055502807e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,2506,101,2.43 [1.80-3.28],6.465916069789131e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,2489,101,3.71 [2.74-5.03],3.286279790396033e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,2481,99,6.36 [4.33-9.33],3.5103952173127794e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,2505,102,4.31 [2.81-6.61],2.4221516533384862e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,2493,102,3.24 [2.33-4.51],2.379431298090672e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,2475,101,4.49 [3.10-6.50],2.0299102984069863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2475,101,3.74 [2.42-5.77],2.662208309019029e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,2375,100,5.32 [3.32-8.53],3.9325617667885055e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,2505,102,5.70 [3.77-8.62],1.5242843495882995e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2506,101,2.44 [1.78-3.34],2.413185811640444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,2385,94,2.27 [1.71-3.00],1.024698173752615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,2505,102,3.32 [2.33-4.72],3.017565409840615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,2143,83,4.37 [2.55-7.48],7.655358351171483e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2483,101,2.63 [1.89-3.65],7.498562871334767e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2140,84,3.14 [2.14-4.59],4.2600696309852225e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,2497,101,3.10 [2.29-4.20],2.569512390386373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,2425,98,1.61 [1.35-1.92],9.693792219967293e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,2492,99,4.20 [2.69-6.55],2.4353564906940183e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,2494,101,3.70 [2.76-4.97],2.365404741561504e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,2500,102,7.60 [4.12-14.02],8.761544540853205e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,2483,101,9.69 [5.41-17.37],2.3785860018338352e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,2510,102,4.24 [3.07-5.84],1.4635789591903342e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,2481,99,7.14 [4.55-11.20],1.1729851105086457e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,2496,99,10.03 [4.95-20.31],1.5351476025897076e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,2496,99,5.13 [3.00-8.78],2.299093661814625e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,2478,98,4.39 [2.89-6.68],4.508939575656818e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2489,101,3.45 [2.20-5.41],7.460724266754435e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,2460,98,3.28 [2.47-4.35],1.6842869331019195e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,2489,101,5.39 [3.49-8.32],3.124779614707723e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,2467,99,4.29 [2.80-6.57],2.2550098315909104e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2500,102,3.90 [3.02-5.04],1.7630912822822289e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2483,99,3.51 [2.28-5.43],1.4371486880728632e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,2488,100,5.28 [3.60-7.75],1.822964839640929e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,2462,98,4.99 [3.55-7.01],1.7713349051704418e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,2393,97,4.24 [3.03-5.93],3.020817239312816e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,2510,102,4.98 [3.28-7.56],4.932102633927022e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,2510,102,3.60 [2.31-5.63],1.7958421734477554e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",2138,84,2.28 [1.73-3.00],4.9760288873546405e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",2510,102,2.04 [1.60-2.61],1.0348639647924464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,2475,101,4.75 [2.85-7.93],2.372258746160104e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,2483,101,6.23 [4.02-9.65],2.715744279651428e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,2495,102,1.73 [1.42-2.11],8.441017732629552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,2421,99,3.99 [2.63-6.05],6.827349788813819e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2463,98,4.04 [2.61-6.25],3.630743804037799e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,2482,99,3.78 [2.57-5.56],1.5426027583710574e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,2510,102,2.50 [2.03-3.07],2.7921190499074226e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,2495,102,6.84 [4.39-10.67],2.021447047214652e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,2463,98,6.65 [3.83-11.54],1.7013029850563398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,2097,81,2.67 [1.89-3.76],2.1949736447797e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,2437,97,2.22 [1.73-2.84],3.3992839501825285e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,2482,100,2.99 [2.14-4.17],1.0267790928830764e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,2499,102,2.13 [1.78-2.56],3.955742888759083e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2477,100,3.57 [2.48-5.15],9.612551522426072e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,2133,83,3.31 [2.22-4.93],4.211726551307218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,2500,102,3.52 [2.53-4.90],6.598386147041975e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2461,98,4.31 [2.88-6.45],1.3443132694288356e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,2475,101,6.33 [3.74-10.74],6.924597337391313e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,2505,102,2.11 [1.66-2.69],1.0774600257491015e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,2463,96,2.65 [2.10-3.34],1.519322818141671e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,2471,99,2.97 [2.13-4.16],1.8829694574923567e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,2510,102,2.77 [2.03-3.79],1.5915115140329694e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,2488,100,6.91 [4.05-11.81],1.4616521223965604e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,2460,100,2.38 [1.73-3.27],8.338753651338062e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,2109,80,2.61 [1.87-3.64],1.7024172991805783e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,2505,102,5.60 [3.74-8.40],7.977101242703688e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,2463,101,3.52 [2.24-5.54],4.8345719090192056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,2500,102,2.17 [1.81-2.61],7.80895694197881e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2506,101,2.98 [2.09-4.24],1.336185355226603e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,2475,101,2.72 [1.95-3.81],4.576566521496305e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2481,99,2.58 [2.04-3.26],1.534579502557182e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,2460,97,3.81 [2.79-5.21],4.895689928137638e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,2397,95,2.42 [1.82-3.22],1.432528714757969e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,2481,99,2.37 [1.82-3.09],1.4530653698354314e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,2484,99,4.46 [2.74-7.23],1.507353707680447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,2477,100,5.60 [3.44-9.13],4.2890022163702004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,2136,83,4.00 [2.56-6.23],9.931995548359726e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2494,102,2.84 [1.97-4.12],2.9489244301168952e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2510,102,3.58 [2.37-5.41],1.258417492266526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2468,99,4.20 [2.83-6.22],8.630890726173369e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,2473,98,2.34 [1.71-3.18],7.442325196399102e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,2489,101,4.75 [2.80-8.08],8.258422043956367e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,2414,94,2.02 [1.60-2.55],2.649973946033518e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2489,101,5.22 [3.16-8.61],1.0049306349163136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,2474,100,3.21 [2.23-4.63],4.3526021740223975e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2130,82,4.35 [2.68-7.05],2.5718406935194277e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,2500,102,6.08 [3.58-10.32],2.4890042091152488e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,2483,101,3.64 [2.43-5.45],3.5072393099707435e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,2489,101,2.83 [2.11-3.79],3.422588484284227e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,2408,94,3.12 [2.44-4.01],2.630610413993516e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,2489,101,0.33 [0.24-0.47],7.47793083750749e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,2506,101,3.84 [2.36-6.26],6.217723137269192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,2112,82,5.40 [3.31-8.80],1.3982775566296088e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,2483,101,3.21 [2.31-4.46],3.983518867917253e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,2490,100,3.04 [2.26-4.08],1.6263275963877172e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,2130,82,2.74 [1.90-3.93],5.182037009175732e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,2475,101,3.83 [2.61-5.61],6.309113596669788e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,2506,101,5.74 [3.68-8.96],1.4754305559189876e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,2447,100,1.74 [1.43-2.12],4.97677189624818e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2490,100,5.12 [3.55-7.38],1.9587721788426817e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,2468,99,5.13 [3.10-8.50],2.2265602574899644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,2496,101,4.05 [2.55-6.43],2.965554243994787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,2147,82,6.49 [3.67-11.48],1.3079632425565216e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,2481,99,4.75 [2.81-8.06],6.790749622715221e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,2457,99,3.19 [2.32-4.39],7.487008127487494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,2484,102,5.49 [3.05-9.88],1.36202785235834e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,2136,83,2.24 [1.70-2.94],7.222023011167627e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,2463,99,2.36 [1.85-3.01],3.431662817752349e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,2488,99,2.84 [2.20-3.66],8.770312406300712e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2490,100,4.04 [2.62-6.24],2.781631997024436e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,2483,101,1.89 [1.63-2.19],3.7467063169499163e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,2148,83,4.89 [2.75-8.70],6.745504377034923e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,2069,79,4.56 [2.76-7.53],2.97405906721629e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,2502,102,3.56 [2.65-4.80],5.773733719973436e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,2096,83,4.88 [2.88-8.27],3.6812159697948636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,2500,102,3.67 [2.37-5.69],5.214388412858444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,2500,102,3.99 [2.60-6.13],2.5021598923622616e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,2505,102,5.74 [3.83-8.60],2.3435142472356722e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,2409,96,3.92 [2.86-5.39],2.653715048556311e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,2505,102,4.85 [3.40-6.92],2.9888693269950645e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,2492,102,4.69 [3.15-6.99],2.909070741910921e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,2421,99,2.42 [1.77-3.32],3.8091538446921575e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,2147,82,4.51 [2.89-7.06],3.7480736902424704e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,2496,99,3.07 [2.23-4.22],5.8453344038836455e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,2463,98,2.09 [1.62-2.69],1.1044675029343588e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,2418,95,2.87 [1.98-4.16],2.6954474490221053e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,2490,100,2.78 [2.16-3.58],1.849312349093146e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,2477,100,2.33 [1.92-2.84],1.852400252853853e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,2488,99,2.90 [1.98-4.25],4.795486076272823e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,2475,100,3.74 [2.47-5.67],4.695857080410242e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,2475,101,3.33 [2.39-4.64],1.3339492170974245e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,2505,102,3.23 [2.12-4.92],4.7306557782732184e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,2479,100,1.69 [1.43-2.00],5.563030460188415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,2492,99,1.98 [1.60-2.45],4.768154424731095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,2462,98,2.24 [1.84-2.73],8.347723508614945e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,2489,101,3.11 [2.31-4.19],7.472494159333477e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,2505,102,4.15 [2.56-6.72],7.095988403046714e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2463,98,2.54 [1.94-3.34],1.9220906343533697e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2463,98,1.73 [1.51-1.97],5.802451848648285e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2506,101,3.11 [2.28-4.24],7.799895495729134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2489,101,4.25 [3.00-6.02],4.2287866529557965e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2488,99,3.87 [2.78-5.38],8.612866718796688e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2500,102,3.35 [2.43-4.62],1.3895383617908068e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2490,100,4.63 [3.15-6.79],5.0032263806266046e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2490,100,2.00 [1.63-2.45],3.9824614707050334e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2501,101,3.64 [2.64-5.02],3.836412800164639e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2463,98,2.24 [1.76-2.86],8.475409369202396e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2496,99,7.05 [4.08-12.18],2.665758048741583e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,2463,98,3.53 [2.42-5.14],5.299419857585641e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,2500,102,0.44 [0.33-0.57],2.1584975426146966e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2133,83,1.84 [1.47-2.29],6.19824756243548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2484,98,2.83 [2.04-3.93],5.207141440437653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,2459,97,3.10 [2.10-4.58],1.3017697412193998e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,2358,93,3.11 [2.33-4.16],1.4702407797028145e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,2421,99,2.33 [1.71-3.18],9.390214038118058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,2497,101,3.85 [2.73-5.44],1.918695939902932e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,2140,84,5.55 [3.24-9.49],4.3136120824927183e-10
